Zobrazeno 1 - 10
of 5 509
pro vyhledávání: '"Kazuma K"'
Autor:
Kato NP, Kinugawa K, Sano M, Kogure A, Sakuragi F, Kobukata K, Ohtsu H, Wakita S, Jaarsma T, Kazuma K
Publikováno v:
Patient Preference and Adherence, Vol 2016, Iss Issue 1, Pp 171-181 (2016)
Naoko P Kato,1–3 Koichiro Kinugawa,1 Miho Sano,4 Asuka Kogure,4 Fumika Sakuragi,5 Kihoko Kobukata,4 Hiroshi Ohtsu,6 Sanae Wakita,4 Tiny Jaarsma,2 Keiko Kazuma7 1Department of Therapeutic Strategy for Heart Failure, The University of Tokyo Graduate
Externí odkaz:
https://doaj.org/article/cbf3ce209492439b861a04588595c633
Autor:
Tetsuro Kawano-Sugaya, Koji Arikawa, Tatsuya Saeki, Taruho Endoh, Kazuma Kamata, Ayumi Matsuhashi, Masahito Hosokawa
Publikováno v:
Microbiome, Vol 12, Iss 1, Pp 1-13 (2024)
Abstract Background The increase in metagenome-assembled genomes (MAGs) has advanced our understanding of the functional characterization and taxonomic assignment within the human microbiome. However, MAGs, as population consensus genomes, often aggr
Externí odkaz:
https://doaj.org/article/1d3fd3db8d0543ed83d8fae559c034cf
Autor:
Naohisa Urabe, Susumu Sakamoto, Nozomi Tokita, Hiromichi Yoshida, Yusuke Usui, Hiroshige Shimizu, Muneyuki Sekiya, Shion Miyoshi, Yasuhiko Nakamura, Kazutoshi Isobe, Kazuma Kishi
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Amikacin liposome inhalation suspension (ALIS) improved sputum culture conversion rate at 6 months for patients with refractory Mycobacterium avium complex pulmonary disease (MAC-PD) in an international phase 3 trial. Patient char
Externí odkaz:
https://doaj.org/article/568eb91efc8a4ed38b6e382449488b1d
Autor:
Ken Asada, Syuzo Kaneko, Ken Takasawa, Kouya Shiraishi, Norio Shinkai, Yoko Shimada, Satoshi Takahashi, Hidenori Machino, Kazuma Kobayashi, Amina Bolatkan, Masaaki Komatsu, Masayoshi Yamada, Mototaka Miyake, Hirokazu Watanabe, Akiko Tateishi, Takaaki Mizuno, Yu Okubo, Masami Mukai, Tatsuya Yoshida, Yukihiro Yoshida, Hidehito Horinouchi, Shun-Ichi Watanabe, Yuichiro Ohe, Yasushi Yatabe, Takashi Kohno, Ryuji Hamamoto
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Background The cancer genome contains several driver mutations. However, in some cases, no known drivers have been identified; these remaining areas of unmet needs, leading to limited progress in cancer therapy. Whole-genome sequencing (WGS)
Externí odkaz:
https://doaj.org/article/5ca317bc30aa4ff796701baac2c9a5a6
Autor:
Kazuma Kawakami
Publikováno v:
Maketingu Janaru, Vol 44, Iss 2, Pp 174-181 (2024)
The sports industry has evolved into a multifaceted industry and it continues to change. Attention is especially focused on spectator sports, and related marketing research is being actively carried out. Many researchers have focused on the perceived
Externí odkaz:
https://doaj.org/article/efffa2fc896a43e3852275e59a15d68d
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Better communication with older people requires not only improving speech intelligibility but also understanding how well emotions can be conveyed and the effect of age and hearing loss (HL) on emotion perception. In this paper, emotion disc
Externí odkaz:
https://doaj.org/article/d509515a5470409490931bda5e7ed2f6
Autor:
Kazuma Kawakami, Kenji Tomita
Publikováno v:
Maketingu Janaru, Vol 44, Iss 1, Pp 86-95 (2024)
Management of medical centers operates in a difficult environment in which limited medical resources must be used effectively and efficiently while paying attention to medical policies and trends of patients. Many medical centers struggle with these
Externí odkaz:
https://doaj.org/article/36ad420122f0442693a77f1b6094d8c4
Publikováno v:
npj Materials Degradation, Vol 8, Iss 1, Pp 1-10 (2024)
Abstract Sensor degradation poses a critical yet ‘often overlooked’ challenge in accurately predicting the remaining useful life (RUL) of nuclear reactor pressure vessels (RPVs), hindering safe and efficient plant operation. This paper introduces
Externí odkaz:
https://doaj.org/article/73ffc98f4baa4d1ab06cdd0ac1b16b34
Autor:
Syuzo Kaneko, Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa, Hidenori Machino, Norio Shinkai, Maiko Matsuda, Mari Masuda, Shungo Adachi, Satoshi Takahashi, Kazuma Kobayashi, Nobuji Kouno, Amina Bolatkan, Masaaki Komatsu, Masayoshi Yamada, Mototaka Miyake, Hirokazu Watanabe, Akiko Tateishi, Takaaki Mizuno, Yu Okubo, Masami Mukai, Tatsuya Yoshida, Yukihiro Yoshida, Hidehito Horinouchi, Shun-Ichi Watanabe, Yuichiro Ohe, Yasushi Yatabe, Vassiliki Saloura, Takashi Kohno, Ryuji Hamamoto
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-17 (2024)
Abstract Background In an extensive genomic analysis of lung adenocarcinomas (LUADs), driver mutations have been recognized as potential targets for molecular therapy. However, there remain cases where target genes are not identified. Super-enhancers
Externí odkaz:
https://doaj.org/article/41d2bbf4f86f4d019c77904a80b740d3
Autor:
Kageaki Watanabe, MD, Yukio Hosomi, MD, PhD, Katsuhiko Naoki, MD, PhD, Yoshiro Nakahara, MD, PhD, Yoko Tsukita, MD, PhD, Hirotaka Matsumoto, MD, PhD, Kiyotaka Yoh, MD, Yasuhito Fujisaka, MD, PhD, Satoshi Takahashi, MD, PhD, Saori Takata, MD, PhD, Kazuhiro Usui, MD, PhD, Kazuma Kishi, MD, PhD, Go Naka, MD, PhD, Shu Tamano, MSS, Kohei Uemura, PhD, Hideo Kunitoh, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 11, Pp 100720- (2024)
Introduction: Osimertinib is used as the first-line treatment for EGFR mutation-positive NSCLC. Nevertheless, its efficacy and safety in clinical practice remain to be fully elucidated and the pattern of progression and the optimal subsequent treatme
Externí odkaz:
https://doaj.org/article/55bb019de54c4270ba80a584e19e9d79